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Abstract 
Introduction: Intestinal inflammation alters colonic afferent nerve sensitivity 
which may contribute to patients´ perception of abdominal discomfort. We 
aimed to explore whether mast cells and the cyclooxygenase pathway are 
involved in altered afferent nerve sensitivity during colitis. 
Methods: C57Bl6 mice received 3 % dextran-sulfate sodium (DSS) in drinking 
water for 7 days to induce colitis. Control animals received regular water. On 
day 8 inflammation was assessed in the proximal colon by morphology and 
histology. Extracellular afferent nerve discharge was recorded from the 
mesenteric nerve of a 2 cm colonic segment. Subgroups were treated in vitro 
with the mast cell stabilizer doxantrazole (10-4 M) or the cyclooxygenase 
inhibitor naproxen (10-5 M). 
Results: DSS colitis resulted in morphological and histological signs of 
inflammation. At baseline, peak firing was 11±2 impsec-1 in colitis segments 
and 5±1 impsec-1 in uninflamed control segments (p<0.05; mean±SEM; each 
n=6). In colitis segments, afferent nerve discharge to bradykinin (0.5 µM) was 
increased to 47±7 compared to 23±6 imp sec-1 in recordings from 
non-inflamed control tissue (p<0.05). Mechanosensitivity during luminal ramp 
distension (0-80 cmH2O) was increased reaching 24±5 impsec
-1 at 80 cmH2O 
during colitis compared to 14±2 in non-inflamed controls (p<0.05). 
Doxantrazole or naproxen reduced afferent discharge to bradykinin and 
luminal ramp distension in colitis segments to control levels. 
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Conclusion: Intestinal inflammation sensitizes mesenteric afferent nerve fibers 
to bradykinin and mechanical stimuli. The underlying mechanism responsible 
for this sensitization seems to involve mast cells and prostaglandins. 
 
Keywords: afferent nerve, colitis, cyclooxygenase, mast cell, visceral 
sensitivity 
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Introduction 
Chronic inflammatory bowel disease (IBD) is characterized by abdominal pain 
and discomfort for affected patients. These symptoms are initiated by the 
release of an array of inflammatory mediators with subsequent sensitization of 
visceral afferent nerves (1). Despite this common knowledge, our 
understanding of mechanisms that may contribute to this sensitization and 
subsequent perception of pain during intestinal inflammation is limited. 
 
Visceral sensitivity during intestinal inflammation is most commonly studied in 
rat or mice by characterization of the viscero-motor response i.e. behaviour 
and/or muscle contraction of the abdominal wall during intestinal distension (2). 
This method is indirect and the viscero-motor response as outcome parameter 
for visceral sensitivity may be modulated at various levels such as the 
intestinal wall, afferent pathways, the central nervous system (CNS), and 
efferent pathways (3, 4). Contrary to this indirect and rather unspecific method 
of studying visceral sensitivity, models of direct recordings from extrinsic 
afferent nerves innervating the intestine allow to measure peripheral afferent 
sensitivity directly without potential modulation in the CNS. These direct 
recordings also allow to test specific chemical or mechanical stimuli and the 
effect of antagonists interfering with the action of different mediators. Thus, 
direct recordings from afferent nerves permit to study the potential involvement 
of different mechanisms specifically (5). 
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Coldwell et al. characterized afferent nerve responses to the mediator 
5-hydroxytryptamine (5-HT) and localized mechanical stimulation of the colon 
to project in the corresponding lumbar splanchnic nerve (6). They found 
increased sensitivity to both stimuli during acute dextran sulphate sodium 
(DSS) induced colitis which persisted for 5-HT after the acute inflammation 
had subsided. Further studies provided evidence that transient receptor 
potentials of the vanilloid type 1 (TRPV1, 7, 8), type 4 (TRPV4, 9), the transient 
receptor potential channel A1 (10), and protease activated receptor PAR2 (9) 
on colonic afferent nerve terminals are involved in afferent sensitization during 
experimental colitis. 
 
In the present study, our interest was to investigate the role of mast cells and 
the cyclooxygenase pathway for afferent sensitivity during colitis. We 
specifically investigated afferent sensitivity to bradykinin (BK) as its release 
and sensitizing action on afferent nerve terminals is a crucial mechanism 
leading to the generation of pain in somatic models (11). For the same reason 
the afferent nerve response to mechanical distension was also tested. 
 
We hypothesized that BK- and mechano-sensitivity of afferent nerve fibers 
innervating the colon is increased during DSS induced colitis, and that mast 
cells and the cyclooxygenase pathway are involved.
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Methods 
 
Animals / DSS colitis 
Experiments were performed with male C57BL/6 mice (Charles River, Sulzfeld, 
Germany) weighing approximately 20g. Animals were held under a 12h/12h 
dark/light cycle with free access to food and water before and during 
experiments. Animal experiments were approved by the local Institutional 
Review Board (Regierung von Oberbayern). Colitis was induced by feeding 
animals 3 % dextran-sulfate sodium (DSS) which was dissolved in the 
animals´ drinking water and given for seven consecutive days as described 
previously (12, 13). Control animals received vehicle only i.e. normal tap water. 
Animals were sacrificed on day eight after the beginning of DSS or vehicle 
administration by inhalation of an anesthetic overdose (Isoflurane, Abbott, 
Baar, Switzerland). Then, after a quick laparotomy, the colon was removed 
with the adjacent mesentery attached. 
 
Tissue preparation for afferent nerve recordings 
The colon and its mesentery were placed in a culture dish containing ice-cold 
Kreb’s solution and the cecum was cut off. Then, under stereoscopic vision 
(operating microscope, Wild M3Z, Heerburg, Switzerland), the mesentery was 
dissected off the colon from distal to proximal except for the first 2 cm of 
proximal colon i.e. the first part distal to the cecum. These 2 cm of ascending 
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colon with the mesentery attached were prepared for afferent nerve 
recordingsrecordings. 
 
Technique of afferent nerve recordings 
The colonic segment was placed into a custom-made organ bath that 
consisted of two chambers. In a perfusion chamber, the segment was 
superfused with Kreb’s buffer gassed with a O2/CO2 mixture (95 % / 5 %; 
composition of Kreb´s (mM): Na+ 143.5, K+ 5.9, Cl- 126, Ca2+ 2.5, Mg2+ 1.2, 
H2PO4 1.2, SO4 1.2, HCO3
- 25, glucose 10 and sodium butyrate 1, pH 7, 
superfused at a rate of 10 ml min-1, temperature 32C). In order to eliminate 
spontaneous colonic motility that rendered afferent nerve recordings 
impossible in pilot experiments, the L-type calcium channel blocker nifedipine 
was added to the perfusion solution at a concentration of 1 µM as described by 
others (14). Continuous superfusion with Kreb’s in the perfusion chamber was 
ensured with the help of a pump (Minipuls 3, Gilson, France).  
 
The mesenteric arcade next to the colonic segment was guided through an 
opening into a recording chamber. The opening was sealed with Vaseline 
before the recording chamber was filled with colourless heavy liquid paraffin 
(32 Celsius) for insulation. Both ends of the colonic segment were cannulated 
and tied. The lumen was continuously perfused with Kreb’s from the proximal 
side of the colon (10 ml per hour), while the distal cannula remained open to 
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atmosphere during the experiment unless mechanical ramp distension was 
performed (see below). Intraluminal pressure was monitored continuously by a 
separate channel in the proximal cannula which was connected to a pressure 
transducer (Neurolog pressure amplifier NL 108, Digitimer Ltd., Welwyn 
Garden City, UK). The pressure at baseline was typically 0.5 - 2 cmH2O.  
In the recording chamber, the mesenteric nerve bundle was dissected out of 
the mesentery attached to the colonic segment. The mesenteric nerve was 
then attached to one arm of a bipolar platinum recording electrode, with a fiber 
of connective tissue wrapped around the other electrode serving as a 
reference. The electrodes were connected to a single channel 1902 
preamplifier/filter (Cambridge Electronic Design (CED), Cambridge, UK), and 
the signal was amplified 10.000 times and filtered with a bandwidth of 100 Hz 
to 1 kHz. Signals from the pressure transducer recording the intraluminal 
intestinal pressure were relayed to another single channel 1902 
preamplifier/filter. The output from the preamplifier/filter and the signals from 
the pressure transducers were transferred to a power Micro 1401 interface 
system (CED) saved and viewed online by running Spike 2 software (version 
4.01; CED).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Experimental protocol 
Once a stable recording from the mesenteric colonic nerve was established for 
15 minutes, spontaneous afferent nerve discharge was recorded at baseline 
for 10 minutes. Then, mechanical stimulation of the colonic segment was 
performed by ramp distension to 80 cmH2O in approximately 120 seconds. For 
this aim, the outlet of the cannula in the lumen of the intestinal segment was 
clamped and perfusion with Kreb’s solution was continued (10 ml per hour). 
Thereafter, the distal outlet was reopened and a minimum of 10 minutes was 
allowed for afferent discharge to return to baseline levels before the perfusion 
was stopped and BK was administered into the organ bath. BK was added in a 
volume of 250 µl from a stock solution of 10 µM for BK resulting in a final 
concentration of 0.5 µM in the perfusion chamber. This dose was determined 
as an intermediate dose in preliminary dose-response experiments (Fig. 1). 
After 2 minutes perfusion was started again in order to wash out BK from the 
organ bath. 
 
Colonic segments were studied from 4 experimental groups (each n=6, one 
segment was harvested from one animal):  
1. Vehicle pretreated control mice 
2. Mice with DSS colitis 
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3. Mice with DSS colitis and administration of the mast cell inhibitor 
doxantrazole (10-4 M) in the organ bath to investigate effects of mast 
cell mediator release on afferent nerve discharge during colitis 
4. Mice with DSS colitis and administration of the cyclooxygenase 
inhibitor naproxen (10-5 M) in the organ bath to investigate effects of 
mediators from the cyclooxygenase pathway on afferent nerve 
discharge during colitis 
 
Preparations in the experimental groups 3. and 4. were superfused with Kreb’s 
(containing nifedipine 1 µM) at baseline before the superfusate was replaced 
by Kreb’s containing nifedipine plus doxantrazole (10-4 M) or naproxen (10-5 M) 
for 15 minutes before distension was started. The protocol was then continued 
as described above. Concentrations of doxantrazole and naproxen were 
chosen according to previous in vitro experiments (15, 16). A potential effect of 
doxantrazole and naproxen on afferent nerve discharge in naïve control 
animals was investigated in a separate series of experiments. 
 
Assessment of colitis 
Animals overall condition was assessed by quantifying loss of total body 
weightbody weight between treatment day one and eight. After harvesting the 
colon, presence of colitis was assessed morphologically by determination of 
colonic length which was measured from the beginning of the ascending colon 
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(without cecum) to the peritoneal deflection of the upper rectum, and ratio 
between colonic weight and length indicating thickening of the colonic wall. 
 
Colonic segments were also harvested from separate colitis and control 
animals that were used exclusively for histological assessment (each n=6). 
Segments were fixed in 4% paraformaldehyde and processed for histology. 
Slides were stained with haematoxylin and eosin. Inflammation was assessed 
by a previously published scoring system (Table 1, 17).  
 
Drugs 
DSS was purchased from MP Biomedicals (Aurora, OH, USA). Doxantrazole, 
naproxen, BK, and heavy liquid paraffin were obtained from Sigma Chemicals, 
Munich, Germany). 
 
Data analysis 
Multi-unit mesenteric afferent nerve recordings contained action potentials with 
different amplitudes and waveforms that were separated from noise and 
artefacts with the help of waveform imaging software (spike2, CED, as above). 
For this purpose, units in the multi-unit signal were identified with spike2, 
separated and those consisting of action potentials were put back together to a 
multi-unit signal that was subsequently quantified. 
 
single-unit analysis by waveform imaging software which is based on different 
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amplitudes and waveforms of action potentials in the multi-unit recording. In 
brief, Spike2 software automatically sets templates for spikes in the recorded 
signal and then counts spikes that match these carefully defined templates 
selectively. Templates from signals that did not resemble action potentials 
eliminated as artefacts. This data is used to construct peri-stimulus histograms 
of individual units within the whole nerve recording. Each template is 
constructed from 65 data points. The parameters used when setting up 
templates for single action potentials could be varied but typically we require at 
least 60% of the data points to match the predefined template with an 
error of < 2%. Details of this waveform based single unit analysis were 
previously published (18). 
 
In general, multi-unit afferent discharge of the mesenteric nerve was evaluated 
as total discharge above baseline. Specifically, afferent nerve firing to 
distension was determined by quantifying the increase of peak firing frequency 
above baseline over a three second period at 20 cmH2O increments in 
intraluminal pressure. The response to BK was expressed as peak increase of 
impulses per second above baseline from a three seconds bin size. Baseline 
discharge frequency was calculated as peak firing for two minutes prior to 
distension of BK administration. Data are given as mean ± SEM and were 
compared by one-way ANOVA and post-hoc Bonferroni correction. Differences 
were considered statistically significant for p < 0.05. 
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Results 
 
Morphology and histology of DSS - colitis  
At day 8 after the beginning of DSS treatment, mice had developed colitis that 
was characterized by diarrhea and visible fecal blood which was observed in 
all DSS-treated animals but never in controls. Colitis was accompanied by 
weight loss, shortening of the colon, and increased ratio of colonic weight / 
length (all p<0.001; Table 2). Histological workup was performed in a 
representative series of six colitis and control animals. It revealed erosions, 
ulcerations, infiltration with polymorphonuclear cells, severe submucosal 
edema, and thickening of the bowel wall in DSS-treated mice (see Fig. 2 for 
representative images). The microscopic score determined by the scoring 
system given in Table 1 was 6.0 ± 0.2 in DSS mice compared to 1.0 ± 0.4 in 
controls (p<0.001; n=6 each). 
 
Mesenteric afferent nerve recordings 
The recording signal was characterized by high amplitude spikes with varying 
amplitudes and waveforms. In addition, smaller spikes were observed during 
recordings that could not be separated from background noise. Thus, only high 
amplitude spikes were further quantified and analyzed as single units by 
waveform discriminator software as described above. 
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The average peak firing frequency at baseline was 11 ± 2 imp sec-1 in colitis 
segments which was higher than 5 ± 1 imp sec-1 in non-inflamed control 
segments (p<0.05). In colitis segments used to study the effect of doxantrazole 
and naproxen, discharge was 10 ± 1 imp sec-1 at baseline following 
doxantrazole administration (10-4 M) and 8 ± 1 imp sec-1 following naproxen 
(10-5 M) which was not different from recordings from colitis segments without 
doxantraozole or naproxen. 
 
BK administration into the organ bath was followed by a robust increase in 
afferent nerve discharge. This increase in discharge was based on 
spontaneously active fibers that increased their discharge frequency and 
recruitment of fibers that were silent at baseline (Figure 3A). Peak increase in 
afferent nerve discharge above baseline to BK was 23 ± 6 imp sec-1 in control 
segments, while an increase of 47 ± 7 imp sec-1 was recorded in colitis 
segments (p<0.05, Figure 3B). Afferent discharge to BK in colitis segments 
was 23 ± 2 imp sec-1 following doxantrazole (10-4 M) and 31 ± 5 imp sec-1 
following naproxen (10-5 M) which was not different from non-inflamed control 
segments. 
 
During continuous ramp distension, a pressure dependent increase in afferent 
nerve discharge above baseline was observed (Figure 4A). Mechanical 
sensitivity in colitis segments was increased compared with non-inflamed 
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control segments over the whole range of distending pressures from 0 to 80 
cmH2O (p<0.05, Figure 4B). Peak discharge of all analyzed units increased 
from 14 ± 2 imp sec-1 in non-inflamed control tissue to 24 ± 5 imp sec-1 in 
colitis segments at 80 cmH2O (p<0.05). Treatment with doxantranzole (10
-4 M) 
or naproxen (10-5 M) reduced the increase of peak afferent discharge at 80 
cmH2O in colitis segments to 13 ± 1 imp sec
-1 and 14 ± 3 imp sec-1 which was 
not different from non-inflamed controls. 
 
Doxantrazole and naproxen were additionally given in naïve control 
experiments and shown to have no effect on mesenteric afferent nerve 
discharge in animals without colitis (Figure 5). 
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Discussion 
This study investigates the role of mast cells and the cyclooxygenase pathway 
for intestinal afferent sensitivity during DSS colitis which is an established 
model of inflammatory bowel disease (12, 13). Mesenteric afferent nerve 
discharge at baseline and to BK and mechanical ramp distension was 
increased during DSS colitis compared to control tissue. Afferent sensitivity to 
both stimuli returned to control levels when colitis segments were pre-treated 
with either the mast cell stabilizer doxantrazole or the non-selective 
cyclooxygenase (COX) inhibitor naproxen in the organ bath. A similar 
presence of inflammation in all colitis subgroups was confirmed by 
macroscopic and histological assessment with an established scoring system.  
 
Baseline discharge was higher in colitis animals compared to normal controls 
which was uninfluenced by doxantrazole or naproxen. This increase in 
discharge during colitis is likely to be attributed to an array of mediators 
released during intestinal inflammation such as cytokines, biogenic amines, 
prostanoids, leucotrienes, nucleosides etc. that have all the potential to 
sensitize afferents (19, 20). As doxantrazole or naproxen only inhibit 
subgroups of these mediators, uninhibited agents are likely to be sufficient to 
maintain sensitization with subsequently increased discharge at baseline. 
Alternatively, differences in afferent discharge in the presence of these 
antagonists may simply be not big enough to be unveiled at baseline in 
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contrast to more pronounced responses that are triggered when additional 
stimuli are administered. 
 
We established a technically challenging novel in vitro preparation to record 
from afferent nerve fibers from the mesentery of the proximal colon. Previous 
reports described multi-unit afferent nerve recordings remote from the colon i.e. 
from the pelvic or splanchnic nerve (6, 8). The advantage of this novel setup is 
that afferent nerve signaling was recorded directly and close to the site of its 
generation, minimizing potential modulatory neural input and allowing a 
precise localization of the corresponding area of the colon which gave rise to 
these afferent nerve signals., where afferent nerve signals originated from.  
 
As for other experimental setups serving to record from colonic afferents in 
vitro (14), it was indispensible to add the L-type Ca2+-channel blocker 
nifedipine to the organ bath because otherwise spontaneous colonic motor 
activity triggers artificial increases in afferent nerve discharge that render 
interpretation of afferent nerve responses to specific stimuli impossible. 
Abundant previous work documents that nifedipine does not eliminate afferent 
discharge to an array of inflammatory mediators sensitizing intestinal afferents 
(18, 21, 22). However, mesenteric afferent firing to more complex stimuli such 
as intestinal ischemia may be reduced by nifedipine, potentially by modulation 
L-type Ca2+-channels which may inhibit mediator release from immune cells 
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(23, 24). Thus, we cannot rule out that nifedipine may have had an attenuating 
effect during colitis, however, as all groups received this agent in an identical 
fashion, modulation of afferent nerve responses by doxantrazole and naproxen 
can nevertheless be attributed to these agents. 
 
Serosal superfusion of the preparation with BK elicited a robust afferent nerve 
response which was increased in colitis animals compared to controls. BK is 
released during inflammation and secondary to tissue damage (25) acting 
subsequently as a key mediator for the generation of pain (11). It binds to two 
G protein-coupled receptors which were named B1 and B2 (26). The B2 
receptor is constitutively expressed and mediates afferent nerve sensitivity in 
naive animals (26, 27). Increased afferent sensitivity to BK during colitis 
suggests that other inflammatory mediators may have sensitized afferent 
nerves to BK. These are likely to originate from mast cells as mast cell 
stabilization by pretreatment with doxantrazole resulted in an afferent nerve 
response which was similar to naïve animals. Among these mast cell 
mediators, prostaglandin E2 (PGE2) is a likely candidate as expression of 
Cox-2 is upregulated during DSS colitis and PGE2 was previously shown to 
sensitize the mesenteric afferent nerve response to BK in naive animals (27). 
Indeed, inhibition of prostaglandins with naproxen also reduced the afferent 
nerve response back to control levels as observed during doxantrazole 
pretreatment. Furthermore, prostaglandins are known to be released during 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
inflammatory responses that are predominantly brought on by mast cells (19, 
20).  
 
Sensitization of the afferent nerve response was also observed during 
continuous intraluminal ramp distension. This way to test mechanosensitivity 
excites different populations of afferent nerve fibers i.e. parasympathetic and 
sympathetic afferents plus centrifugal fibers projecting to the prevertebral 
ganglia (28). The latter population is small and its contribution to the afferent 
nerve response was previously shown to be neglectable (29), while the bulk of 
afferent firing consists of low-threshold parasympathetic afferents and 
wide-dynamic range and high-threshold afferents of sympathetic origin (29, 30, 
31). Thus, afferent nerve discharge at low distension pressures stems 
predominantly from parasympathetic afferents and at high distension 
pressures (representing a noxious event) from sympathetic afferents (30, 31). 
In the present study, the afferent nerve response was sensitized over the 
whole pressure range in colitis animals compared to controls. This suggests 
that both types of afferent nerve endings were sensitized, i. e. parasympathetic 
and sympathetic afferent nerve endings.  
 
Increased responses during mechanical ramp distension may be explained by 
a permissive action of other proinflammatory mediators that were released 
during DSS colitis. Among these are several mast cell mediators such as 5-HT 
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and histamine which are known to sensitize parasympathetic nerve endings 
(14, 18, 21), and prostaglandins and kinins (27) which are known to sensitize 
predominantly sympathetic afferents. Furthermore, some mediators such as 
adenosine exist that have the potential to sensitize both parasympathetic and 
sympathetic afferents (32, 33). As for bradykinin, afferent nerve responses to 
mechanical ramp distension were reduced by both, the mast cell stabilizer 
doxantrazole and the cyclooxygenase inhibitor naproxen. There are several 
possible explanations for this phenomenon that both drugs worked. One is that 
DSS colitis triggers the release of a “soup” of inflammatory mediators that all 
sensitize afferents in a joint action. Thus, reducing different components by 
different inhibitors in such a “soup” may have a similar effects on afferent nerve 
discharge to bradykinin and mechanical stimulation. Another likely explanation 
is that mast cell action on afferent nerve terminals works predominantly via 
prostanoids from mast cells. This would also explain why both, 
pharmacological mast cell stabilization and inhibition of prostanoid release 
have a similar effect on afferent nerve discharge. 
 
In conclusion DSS colitis is accompanied by inflammation that is characterized 
by morphological alterations of the proximal colon. Afferent sensitivity to BK 
and to mechanical stimuli of different intensity is increased during DSS colitis 
suggesting that parasympathetic and sympathetic afferent nerve fibers are 
sensitized during DSS induced colitis. The underlying mechanisms seem to 
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involve mast cells and the cyclooxygenase pathway, so that mast cell 
stabilization and/or COX inhibition represent potential strategies to reduce 
afferent sensitization and subsequent pain during colitis. 
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Legends 
 
Figure 1 
Dose-response relationship for mesenteric afferent nerve discharge to rising 
doses of serosal bradykinin. Note that the 0.5 µM dose is neither a minimal nor 
a submaximal dose as regards the response in afferent nerve discharge. d/c: 
discharge; white bar: 0.25 µM, bar with horizontal stripes: 0.5 µM, black bar: 1 
µM. Data are mean±SEM (n=6). 
 
Figure 2 
Hematoxilin and Eosin staining of colon from a DSS pretreated animal with 
colitis (left) and a control animal that received vehicle (right). During DSS 
colitis, crypts were absent in large areas, wall thickness was increased, and 
cellular infiltrates were observed in all layers of the gut wall. Scale bars are 
0.5 cm. 
 
Figure 3 
Panel A shows a r: Representative recording and analysis of an afferent nerve 
response to bradykinin in a control animal (BK; 0.5 µM). BK administration into 
the organ bath was followed by a robust increase in afferent nerve discharge 
which is shown by the raw nerve signal (top trace). Sequential rate histograms 
below depict the number of impulses during the multi-unit afferent nerve 
response .  
Panel B displays a corresponding recording from a colitis animal that was 
pretreated with DSS. 
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Panel CB summarizes the afferent nerve discharge data which are given as 
peak discharge above baseline (white bar: controls, black bar: colitis; 
horizontal stripes: colitis plus doxantrazole (10-4 M); oblique stripes: colitis plus 
naproxen (10-5 M)). Note that both doxantrazole and naproxen reduced 
afferent nerve discharge to BK during intestinal inflammation when compared 
to vehicle controls (all n=6, mean±SEM; *p<0.05 versus control, #p<0.05 
versus colitis). 
 
Figure 4 
Recordings of afferent nerve discharge following intraluminal ramp distension 
serving as a mechanical stimulus. A: Representative recording from a control 
experiment. The upper trace shows the raw nerve recording, while the middle 
trace displays the multi-unit afferent nerve response in sequential rate 
histograms of mesenteric afferent nerve discharge frequency. Pressures 
during ramp distension are given in the bottom trace. B: Corresponding 
recording from a colitis animal that was pretreated with DSS. 
 CB: This diagram shows summarized data of peak afferent nerve discharge 
above baseline in each experimental group. Note that pre-treatment with 
doxantrazole (10-4 M) and Naproxen (10-5 M) in the organ bath prevented an 
increase in afferent nerve discharge during intestinal inflammation when 
compared to vehicle controls (all n=6, mean ± SEM; *p<0.05 versus control, 
#p<0.05 versus inflammation). 
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Figure 5 
Afferent discharge from mesenteric colonic afferents in naïve animals (no 
DSS-colitis) during vehicle (white bars), naproxen (oblique bars; 10-5 M) or 
doxantrazole (10-4 M; horizontal striped bars). Panel A shows afferent 
discharge to bradykinin (0.5 µM) which is not different in the three subgroups 
(n.s.; mean±SEM; n=6). Panel B shows afferent discharge during continuous 
intraluminal ramp distension at different luminal pressure levels. No difference 
was observed following pretreatment with naproxen or doxantrazole compared 
to vehicle controls (n.s.; mean±SEM; n=6). 
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Table 1  
Scoring system for histological assessment of inflammation (see reference 14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epithelium         
     Normal morphology 0 
     Loss of goblet cells 1 
     Loss of goblet cells in large areas 
     Loss of crypts 
     Loss of crypts in large areas  
2 
3 
4 
Infiltration  
     No infiltrates 0 
     Infiltrate around crypt basis 
     Infiltrate reaching to L. muscularis mucosae 
1 
2 
     Extensive infiltration reaching the 
     L. muscularis mucosae and thickening of  
     mucosa with severe oedema 
     Infiltration of the L. submucosa   
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Table 2 
 
 
 
 
Body weight 
change (g) 
Colonic 
length (cm) 
Colonic weight/length 
ratio (mg cm
-1
) 
Controls 2.0 ± 0.4 5.9 ± 0.2 30.5 ± 0.6 
DSS colitis - 4.4 ± 0.4* 3.3 ± 0.2* 38.6 ± 1.3* 
DSS colitis plus pre-treatment 
with doxantrazole in vitro 
- 4.2 ± 0.5* 3.6 ± 0.1* 38.5 ± 2.0* 
DSS colitis plus pre-treatment 
with naproxen in vitro 
- 4.5 ± 0.3* 3.4 ± 0.2* 38.0 ± 1.4* 
 
Data characterizing DSS colitis induced by adding DSS (3 %) in the animals´ 
drinking water for 7 days. Control mice received normal tap water. Mice had 
colitis at day 8 after the beginning of DSS treatment characterized by weight 
loss, colonic shortening, and thickening of the colonic wall expressed as 
weight / length ratio. Data are mean ± SEM, *p<0.001 compared to controls 
(ANOVA). 
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